US Zimmer deal boosts Smith & Nephew shares April 24, 2014 SHARES in Smith & Nephew jumped over three per cent yesterday following the buy-out of a group that tried to buy the British health firm back in 2011. New York-listed Zimmer revealed that it is snapping up rival US orthopaedic company Biomet for $13.35bn (£7.95bn). The deal has added more weight to a widely-held view [...]
Smith & Nephew hit by rejection October 28, 2005 Europe’s largest seller of orthopaedic devices saw its shares tumble to a two-year low after it abandoned producing a key leg ulcer treatment when America turned it down, but its sales are up. Smith & Nephew has abandoned production of a key leg ulcer treatment after it failed to win approval for the American market. [...]